Market revenue in 2023 | USD 3,183.2 million |
Market revenue in 2030 | USD 14,445.9 million |
Growth rate | 24.1% (CAGR from 2023 to 2030) |
Largest segment | Pcr technology |
Fastest growing segment | NGS Technology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies |
Key market players worldwide | Basf SE, Codexis Inc, Illumina Inc, Merck KGaA, New England Biolabs, Eurofins Scientific SE, Novozymes, DNAstar, Synthego, Thermo Fisher Scientific Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to synthetic biology market will help companies and investors design strategic landscapes.
Pcr technology was the largest segment with a revenue share of 27.45% in 2023. Horizon Databook has segmented the Asia Pacific synthetic biology market based on ngs technology, pcr technology, genome editing technology, bioprocessing technology, other technologies covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific region is expected to exhibit significant market growth in the coming years. Rising investments in Asia Pacific countries, increasing partnerships & funding in China market, and increasing collaborations in the field of synthetic biology are among factors anticipated to drive growth of synthetic biology market.
Moreover, several Asian countries have recently established national institutes, state sponsored research programs, and academia-industry collaborations to promote technological innovation for advancement of synthetic biology.
In Asia, market penetration is growing. Integrated DNA Technologies (IDT), a major operator in custom DNA synthesis, opened its manufacturing facility in Singapore in 2013 to provide its synthetic biology products in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific synthetic biology market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific synthetic biology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account